Platinum Resistance: The Role of DNA Repair Pathways
MARTIN, Lainie P, HAMILTON, Thomas C, SCHILDER, Russell J
Published in Clinical cancer research (01.03.2008)
Published in Clinical cancer research (01.03.2008)
Get full text
Journal Article
Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study
Moore, Kathleen N, Martin, Lainie P, O'Malley, David M, Matulonis, Ursula A, Konner, Jason A, Perez, Raymond P, Bauer, Todd M, Ruiz-Soto, Rodrigo, Birrer, Michael J
Published in Journal of clinical oncology (01.04.2017)
Published in Journal of clinical oncology (01.04.2017)
Get full text
Journal Article
Evaluation of Prophylactic Corticosteroid Eye Drop Use in the Management of Corneal Abnormalities Induced by the Antibody-Drug Conjugate Mirvetuximab Soravtansine
Matulonis, Ursula A, Birrer, Michael J, O'Malley, David M, Moore, Kathleen N, Konner, Jason, Gilbert, Lucy, Martin, Lainie P, Bauer, Todd M, Oza, Amit M, Malek, Karim, Pinkas, Jan, Kim, Stella K
Published in Clinical cancer research (15.03.2019)
Published in Clinical cancer research (15.03.2019)
Get full text
Journal Article
A review of mirvetuximab soravtansine in the treatment of platinum-resistant ovarian cancer
Moore, Kathleen N, Martin, Lainie P, O'Malley, David M, Matulonis, Ursula A, Konner, Jason A, Vergote, Ignace, Ponte, Jose F, Birrer, Michael J
Published in Future oncology (London, England) (01.01.2018)
Published in Future oncology (London, England) (01.01.2018)
Get full text
Journal Article
Phase II evaluation of dalantercept in the treatment of persistent or recurrent epithelial ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study
Burger, Robert A., Deng, Wei, Makker, Vicky, Collins, Yvonne, Gray, Heidi, Debernardo, Robert, Martin, Lainie P., Aghajanian, Carol
Published in Gynecologic oncology (01.09.2018)
Published in Gynecologic oncology (01.09.2018)
Get full text
Journal Article
Phase Ib study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer
O'Malley, David M., Matulonis, Ursula A., Birrer, Michael J., Castro, Cesar M., Gilbert, Lucy, Vergote, Ignace, Martin, Lainie P., Mantia-Smaldone, Gina M., Martin, Antonio González, Bratos, Raquel, Penson, Richard T., Malek, Karim, Moore, Kathleen N.
Published in Gynecologic oncology (01.05.2020)
Published in Gynecologic oncology (01.05.2020)
Get full text
Journal Article
First-in-Human Study of AMG 820, a Monoclonal Anti-Colony-Stimulating Factor 1 Receptor Antibody, in Patients with Advanced Solid Tumors
Papadopoulos, Kyriakos P, Gluck, Larry, Martin, Lainie P, Olszanski, Anthony J, Tolcher, Anthony W, Ngarmchamnanrith, Gataree, Rasmussen, Erik, Amore, Benny M, Nagorsen, Dirk, Hill, John S, Stephenson, Jr, Joe
Published in Clinical cancer research (01.10.2017)
Published in Clinical cancer research (01.10.2017)
Get full text
Journal Article
Is Targeting the Folate Receptor in Ovarian Cancer Coming of Age?
Birrer, Michael J., Betella, Ilaria, Martin, Lainie P., Moore, Kathleen N.
Published in The oncologist (Dayton, Ohio) (01.04.2019)
Published in The oncologist (Dayton, Ohio) (01.04.2019)
Get full text
Journal Article
Phase II study of the PI3K inhibitor pilaralisib (SAR245408; XL147) in patients with advanced or recurrent endometrial carcinoma
Matulonis, Ursula, Vergote, Ignace, Backes, Floor, Martin, Lainie P, McMeekin, Scott, Birrer, Michael, Campana, Frank, Xu, Yi, Egile, Coumaran, Ghamande, Sharad
Published in Gynecologic oncology (01.02.2015)
Published in Gynecologic oncology (01.02.2015)
Get full text
Journal Article
Combination ATR and PARP Inhibitor (CAPRI): A phase 2 study of ceralasertib plus olaparib in patients with recurrent, platinum-resistant epithelial ovarian cancer
Shah, Payal D., Wethington, Stephanie L., Pagan, Cheyenne, Latif, Nawar, Tanyi, Janos, Martin, Lainie P., Morgan, Mark, Burger, Robert A., Haggerty, Ashley, Zarrin, Haley, Rodriguez, Diego, Domchek, Susan, Drapkin, Ronny, Shih, Ie-Ming, Smith, Simon A., Dean, Emma, Gaillard, Stéphanie, Armstrong, Deborah, Torigian, Drew A., Hwang, Wei-Ting, Giuntoli, Robert, Simpkins, Fiona
Published in Gynecologic oncology (01.11.2021)
Published in Gynecologic oncology (01.11.2021)
Get full text
Journal Article
Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer
Chan, John K, Brady, Mark F, Penson, Richard T, Huang, Helen, Birrer, Michael J, Walker, Joan L, DiSilvestro, Paul A, Rubin, Stephen C, Martin, Lainie P, Davidson, Susan A, Huh, Warner K, O’Malley, David M, Boente, Matthew P, Michael, Helen, Monk, Bradley J
Published in The New England journal of medicine (25.02.2016)
Published in The New England journal of medicine (25.02.2016)
Get full text
Journal Article
Phase I combination study of the PARP inhibitor veliparib plus carboplatin and gemcitabine in patients with advanced ovarian cancer and other solid malignancies
Gray, Heidi J., Bell-McGuinn, Katherine, Fleming, Gini F., Cristea, Mihaela, Xiong, Hao, Sullivan, Danielle, Luo, Yan, McKee, Mark D., Munasinghe, Wijith, Martin, Lainie P.
Published in Gynecologic oncology (01.03.2018)
Published in Gynecologic oncology (01.03.2018)
Get full text
Journal Article
A Phase I Study of the SMAC-Mimetic Birinapant in Adults with Refractory Solid Tumors or Lymphoma
Amaravadi, Ravi K, Schilder, Russell J, Martin, Lainie P, Levin, Myron, Graham, Martin A, Weng, David E, Adjei, Alex A
Published in Molecular cancer therapeutics (01.11.2015)
Published in Molecular cancer therapeutics (01.11.2015)
Get full text
Journal Article
Safety and activity findings from a phase 1b escalation study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with carboplatin in patients with platinum-sensitive ovarian cancer
Moore, Kathleen N., O'Malley, David M., Vergote, Ignace, Martin, Lainie P., Gonzalez-Martin, Antonio, Malek, Karim, Birrer, Michael J.
Published in Gynecologic oncology (01.10.2018)
Published in Gynecologic oncology (01.10.2018)
Get full text
Journal Article
Characterization of folate receptor alpha (FRα) expression in archival tumor and biopsy samples from relapsed epithelial ovarian cancer patients: A phase I expansion study of the FRα-targeting antibody-drug conjugate mirvetuximab soravtansine
Martin, Lainie P., Konner, Jason A., Moore, Kathleen N., Seward, Shelly M., Matulonis, Ursula A., Perez, Raymond P., Su, Ying, Berkenblit, Anna, Ruiz-Soto, Rodrigo, Birrer, Michael J.
Published in Gynecologic oncology (01.11.2017)
Published in Gynecologic oncology (01.11.2017)
Get full text
Journal Article
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer
Moore, Kathleen N, Angelergues, Antoine, Konecny, Gottfried E, García, Yolanda, Banerjee, Susana, Lorusso, Domenica, Lee, Jung-Yun, Moroney, John W, Colombo, Nicoletta, Roszak, Andrzej, Tromp, Jacqueline, Myers, Tashanna, Lee, Jeong-Won, Beiner, Mario, Cosgrove, Casey M, Cibula, David, Martin, Lainie P, Sabatier, Renaud, Buscema, Joseph, Estévez-García, Purificación, Coffman, Lan, Nicum, Shibani, Duska, Linda R, Pignata, Sandro, Gálvez, Fernando, Wang, Yuemei, Method, Michael, Berkenblit, Anna, Bello Roufai, Diana, Van Gorp, Toon
Published in The New England journal of medicine (07.12.2023)
Published in The New England journal of medicine (07.12.2023)
Get full text
Journal Article
Phase 1b study of mirvetuximab soravtansine, a folate receptor alpha (FRα)–targeting antibody-drug conjugate, in combination with carboplatin and bevacizumab in patients with platinum-sensitive ovarian cancer
Richardson, Debra L., Moore, Kathleen N., Vergote, Ignace, Gilbert, Lucy, Martin, Lainie P., Mantia-Smaldone, Gina M., Castro, Cesar M., Provencher, Diane, Matulonis, Ursula A., Stec, James, Wang, Yuemei, Method, Michael, O'Malley, David M.
Published in Gynecologic oncology (01.06.2024)
Published in Gynecologic oncology (01.06.2024)
Get full text
Journal Article
Randomized Phase II Evaluation of Bevacizumab Versus Bevacizumab Plus Fosbretabulin in Recurrent Ovarian, Tubal, or Peritoneal Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study
Monk, Bradley J, Sill, Michael W, Walker, Joan L, Darus, Christopher J, Sutton, Gregory, Tewari, Krishnansu S, Martin, Lainie P, Schilder, Jeanne M, Coleman, Robert L, Balkissoon, Jai, Aghajanian, Carol
Published in Journal of clinical oncology (01.07.2016)
Published in Journal of clinical oncology (01.07.2016)
Get full text
Journal Article
[18F]FluorThanatrace ([18F]FTT) PET Imaging of PARP-Inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a Pilot Study
Pantel, Austin R, Gitto, Sarah B, Makvandi, Mehran, Kim, Hyoung, Medvedv, Sergey, Weeks, Joanna K, Torigian, Drew A, Hsieh, Chia-Ju, Ferman, Benjamin, Latif, Nawar A, Tanyi, Janos L, Martin, Lainie P, Lanzo, Shannon M, Liu, Fang, Cao, Quy, Mills, Gordon B, Doot, Robert K, Mankoff, David A, Mach, Robert H, Lin, Lilie L, Simpkins, Fiona
Published in Clinical cancer research (14.04.2023)
Published in Clinical cancer research (14.04.2023)
Get full text
Journal Article
Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study
Landen, Charles N, Buckanovich, Ronald J, Sill, Michael W, Mannel, Robert S, Walker, Joan L, DiSilvestro, Paul A, Mathews, Cara A, Mutch, David G, Hernandez, Marcia L, Martin, Lainie P, Bishop, Erin, Gill, Sarah E, Gordinier, Mary E, Burger, Robert A, Aghajanian, Carol, Liu, Joyce F, Moore, Kathleen N, Bookman, Michael A
Published in Journal of clinical oncology (20.07.2024)
Published in Journal of clinical oncology (20.07.2024)
Get full text
Journal Article